Patents Assigned to Pride Proteomics A/S
  • PROTEINS IN TYPE 2 DIABETES
    Publication number: 20090155814
    Abstract: The present invention relates to the use of naturally occurring compounds and derivatives thereof as markers for predisposition of diabetes related diseases. The invention also relates to a pharmaceutical composition for treatment of diabetes related diseases.
    Type: Application
    Filed: November 19, 2008
    Publication date: June 18, 2009
    Applicant: PRIDE PROTEOMICS A/S
    Inventors: Kurt HOJLUND, Stephen J. Fey, Peter Mose Larsen, Henning Beck-Neilsen, Krzysztof Wrzesinski
  • Human diabetes-mediating proteins
    Patent number: 7521193
    Abstract: Determining the expression level of certain diabetes-mediating proteins provides an approach both for diagnosing diabetes and for ascertaining a predisposition for developing diabetes.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: April 21, 2009
    Assignee: Pride Proteomics A/S
    Inventors: Peter Mose Larsen, Stephen J. Fey, Jørn Nerup, Allan E. Karlsen
  • Proteins in type 2 diabetes
    Patent number: 7470542
    Abstract: The present invention relates to the use of naturally occurring compounds and derivatives thereof as markers for predisposition of diabetes related diseases. The invention also relates to a pharmaceutical composition for treatment of the diabetes related diseases.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: December 30, 2008
    Assignee: Pride Proteomics A/S
    Inventors: Kurt Højlund, Stephen J. Fey, Peter Mose Larsen, Henning Beck-Nielsen, Krzysztof Wrzesinski
  • METHOD FOR DIAGNOSING DIABETES IN A MAMMAL
    Publication number: 20080145868
    Abstract: Provided are mammalian secreted and non-secreted diabetes mediating proteins, including protective and deleterious diabetes-mediating proteins, as well as polynucleotides encoding same, drug screening methods for identifying a test compound capable of altering the expression of a diabetes-mediating protein, and methods of preventing or ameliorating diabetes by administering a compound capable of the expression of a diabetes-mediating protein.
    Type: Application
    Filed: October 9, 2007
    Publication date: June 19, 2008
    Applicant: PRIDE PROTEOMICS A/S
    Inventors: Peter Mose Larsen, Stephen J. Fey, Allan E. Karlsen, Thomas Sparre, Jorn Nerup
  • Method for diagnosing diabetes in a mammal
    Patent number: 7279274
    Abstract: Provided are mammalian secreted and non-secreted diabetes mediating proteins, including protective and deleterious diabetes-mediating proteins, as well as polynucleotides encoding same, drug screening methods for identifying a test compound capable of altering the expression of a diabetes-mediating protein, and methods of preventing or ameliorating diabetes by administering a compound capable of the expression of a diabetes-mediating protein.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: October 9, 2007
    Assignee: Pride Proteomics A/S
    Inventors: Peter Mose Larsen, Stephen J. Fey, Allan E. Karlsen, Thomas Sparre, Jorn Nerup